Disclosure by Sponsor Sample Clauses

Disclosure by Sponsor. The Institution and Principal Investigator 7.6 Zpřístupnění informací ze strany zadavatele. Zdravotnické zařízení a hlavní acknowledge that the Sponsor is required by applicable laws and pharmaceutical industry codes of conduct to document and publicly disclose certain transfers of value made to healthcare professionals and healthcare organizations, and such disclosures may include information about the payments or other transfers of value provided to Institution and/or the Principal Investigator and Study Staff under this Agreement [including any financial or in- kind support that the Sponsor may provide in connection with any Manuscript]. The Sponsor may store and use information relating to the Institution, Principal Investigator and/or Study Staff and arising out of this Agreement for the purpose of its business and may publicly disclose in its discretion such information (including, but not limited to, the name and professional address of the Institution and/or the Principal Investigator and Study Staff, any financial and in-kind payments received under this Agreement, the nature of the engagement and any other payment or service-related information) as may be deemed appropriate by Sponsor for the fulfillment of its transparency obligations or as may otherwise be dictated by Applicable Law or any pharmaceutical industry codes of conduct to which the Sponsor or any of its Affiliates is subject. For such purposes, the Sponsor may transfer such information to its Affiliates and/or third party service providers, who may be established in a different jurisdiction to the Institution and Principal Investigator, which jurisdiction may not offer the same level of protection for personal information. Payments to the Institution for work done by specified individuals may reference both the Institution and the individual. In accordance with applicable data protection laws, the Principal Investigator and Study zkoušející berou na vědomí, že příslušné zákony a kodexy správné praxe ve farmaceutickém průmyslu zadavateli ukládají povinnost dokumentovat a veřejně zpřístupnňovat určité převody hodnot na pracovníky ve zdravotnictví a zdravotnická zařízení, a že takto mohou být zpřístupněny informace o platbách a jiných převodech hodnot poskytnutých zdravotnickému zařízení a/nebo hlavnímu zkoušejícímu a personálu studie podle této smlouvy [včetně jakékoli věcné či finanční podpory případně poskytnuté zadavatelem v souvislosti s rukopisem]. Zadavatel může uchovávat a použí...
Sample 1
AutoNDA by SimpleDocs
Disclosure by Sponsor. The Institution and Principal Investigator acknowledge that the Sponsor is required by applicable laws and pharmaceutical industry codes of conduct to document and publicly disclose certain transfers of value made to healthcare professionals and healthcare organizations, and such disclosures may include information about the payments or other transfers of value provided to Institution and/or the Principal Investigator and Study Staff under this Agreement [including any financial or in- kind support that the Sponsor may provide in connection with any Manuscript]. The Sponsor may store and use information relating to the Institution, Principal Investigator and/or Study Staff and arising out of this Agreement for the purpose of its business and may publicly disclose in its discretion such information (including, but not limited to, the name and professional address of the Institution and/or the Principal Investigator and Study Staff, any financial and in-kind payments received under this Agreement, the nature of the engagement and any other payment or service-related information) as may be deemed appropriate by Sponsor for the fulfillment of its transparency obligations or as may otherwise be dictated by Applicable Law or any pharmaceutical industry codes of conduct to which the Sponsor or any of its Affiliates is subject. For such purposes, the Sponsor may transfer such information to its Affiliates and/or third party service providers, who may be established in a 7.6 Zpřístupnění informací ze strany zadavatele. Zdravotnické zařízení a hlavní zkoušející berou na vědomí, že příslušné zákony a kodexy správné praxe ve farmaceutickém průmyslu zadavateli ukládají povinnost dokumentovat a veřejně zpřístupňovat určité převody hodnot na pracovníky ve zdravotnictví a zdravotnická zařízení, a že takto mohou být zpřístupněny informace o platbách a jiných převodech hodnot poskytnutých zdravotnickému zařízení a/nebo hlavnímu zkoušejícímu a personálu studie podle této smlouvy [včetně jakékoli věcné či finanční podpory případně poskytnuté zadavatelem v souvislosti s rukopisem]. Zadavatel může uchovávat a používat informace související se zdravotnickým zařízením, hlavním zkoušejícím a/nebo personálem studie, které povstávají z této smlouvy, pro své obchodní účely, a podle svého uvážení může takové informace veřejně zpřístupnit (zejména název a adresu zdravotnického zařízení a/nebo jméno a adresu zaměstnání hlavního zkoušejícího a personálu studie, jakékoli platby nebo věcné...
Sample 1
Disclosure by Sponsor. The Sponsor may publicly disclose in its discretion in accordance with the information maintained in Sponsor’s internal business records the name of the Institution and/or the Principal Investigator and Study Staff and certain information relating to this Agreement including, but not limited to, any financial and in-kind payments received under this Agreement, the nature of the engagement and any other payment or service-related information as may be deemed appropriate by Sponsor or as may be dictated by Applicable Law. Payments to the Institution for work done by specified individuals may reference both the Institution and the individual. 7.7
Sample 1
Disclosure by Sponsor. In the interest of transparency relating to Sponsor's financial relationships with clinical investigators and clinical study sites, Sponsor may publicly disclose the funding associated with this Agreement or if applicable any other benefit provided to Investigator or Institution by Sponsor or Covance, including, but not limited to, payments made to institutions and payments made or attributable to Investigator or other individuals directly or indirectly, and value associated with meals or travel expenses if applicable.
Sample 1
Disclosure by Sponsor. In the interest of transparency relating to the Sponsor's financial relationships with clinical investigators and clinical study sites, the Sponsor may collect, aggregate, report and otherwise publicly disclose the funding associated with this Agreement, including payments made to institutions and payments made to individuals. Zveřejnění informací zadavatelem. V zájmu transparentnosti finančního vztahu zadavatele s klinickými zkoušejícími a pracovišti klinických studií může zadavatel shromažďovat, seskupovat, vykazovat a jinak zveřejňovat financování spojené s touto smlouvou, včetně plateb zaplacených zdravotnickým zařízením a jednotlivcům.
Sample 1

Related to Disclosure by Sponsor

  • Stockholder Has Adequate Information Stockholder is a sophisticated seller with respect to the Securities and has adequate information concerning the business and financial condition of the Company to make an informed decision regarding the sale of the Securities and has independently and without reliance upon either the Merger Sub or the Parent and based on such information as Stockholder has deemed appropriate, made its own analysis and decision to enter into this Agreement. Stockholder acknowledges that neither the Merger Sub nor the Parent has made and neither makes any representation or warranty, whether express or implied, of any kind or character except as expressly set forth in this Agreement. Stockholder acknowledges that the agreements contained herein with respect to the Securities by Stockholder are irrevocable (prior to the Termination Date).

  • DISCLOSURE; ACCESS TO INFORMATION The Investor has received all documents, records, books and other publicly available information pertaining to Investor's investment in the Company that have been requested by the Investor. The Company is subject to the periodic reporting requirements of the Exchange Act, and the Investor has reviewed copies of all SEC Documents deemed relevant by Investor.

  • Relationship Disclosure Form The purpose of this form is to document any relationships between a bidder to an Orange County solicitation and the Mayor or any other member of Orange County, Florida. This form shall be completed and submitted with the applicable bid to an Orange County solicitation. No contract award shall be made unless these forms have been completed and submitted with the bid. Any questions concerning these forms shall be addressed to the contracting agent identified in this solicitation. Also, a listing of the most frequently asked questions concerning these forms is attached to each for your information.

  • Master Servicer’s Financial Statements and Related Information For each year this Agreement is in effect, the Master Servicer shall submit to the Trustee, any NIMS Insurer, each Rating Agency and the Depositor a copy of its annual unaudited financial statements on or prior to March 15 of each year, beginning March 15, 2006. Such financial statements shall include a balance sheet, income statement, statement of retained earnings, statement of additional paid-in capital, statement of changes in financial position and all related notes and schedules and shall be in comparative form, certified by a nationally recognized firm of Independent Accountants to the effect that such statements were examined and prepared in accordance with generally accepted accounting principles applied on a basis consistent with that of the preceding year.

  • LIFE COMPANY TO PROVIDE DOCUMENTS; INFORMATION ABOUT AVIF (a) LIFE COMPANY will provide to AVIF or its designated agent at least one (1) complete copy of all SEC registration statements, Account Prospectuses, reports, any preliminary and final voting instruction solicitation material, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to each Account or the Contracts, contemporaneously with the filing of such document with the SEC or other regulatory authorities.

  • OBLIGATIONS AND ACTIVITIES OF CONTRACTOR AS BUSINESS ASSOCIATE 1. Contractor agrees not to use or further disclose PHI County discloses to Contractor other than as permitted or required by this Business Associate Contract or as required by law.

  • Listing Information Confidentiality BellSouth will accord <<customer_name>>’s directory listing information the same level of confidentiality that BellSouth accords its own directory listing information, and BellSouth shall limit access to <<customer_name>>’s customer proprietary confidential directory information to those BellSouth employees or agents who are involved in the preparation of listings or directories.

  • Field Audits and Examination Reports; Confidentiality; Disclaimers by Lenders; Other Reports and Information By becoming a party to this Agreement, each Lender:

  • NEPOTISM DISCLOSURE A. In this section the term “relative” means:

  • SEC Filings; Financial Statements; Information Provided (a) The Company has provided to the Buyer true and complete copies of all Company SEC Reports filed with the SEC prior to the date hereof. All registration statements, forms, reports and other documents (including those that the Company may file after the date hereof until the Closing) filed with the SEC are referred to herein as the “Company SEC Reports.” Except as set forth in Section 3.4(a) of the Company Disclosure Schedule, the Company SEC Reports (i) were or will be filed on a timely basis, (ii) at the time filed, were or will be prepared in compliance in all material respects with the applicable requirements of the Securities Act of 1933, as amended (the “Securities Act”), the Exchange Act, as the case may be, and, if applicable, the Xxxxxxxx-Xxxxx Act of 2002 (the “Xxxxxxxx-Xxxxx Act”), and the rules and regulations of the SEC thereunder applicable to such Company SEC Reports, and (iii) did not or will not at the time they were or are filed contain any untrue statement of a material fact or omit to state a material fact required to be stated in such Company SEC Reports or necessary in order to make the statements in such Company SEC Reports, in light of the circumstances under which they were made, not misleading. No Subsidiary of the Company is subject to the reporting requirements of Section 13(a) or Section 15(d) of the Exchange Act. Since March 7, 2000, the Company has filed with the SEC all registration statements, forms, reports and other documents required to be filed under the Securities Act, the Exchange Act, the Xxxxxxxx-Xxxxx Act and the rules and regulations of the SEC thereunder (including those that are required to be filed after the date hereof until the Closing).

Time is Money Join Law Insider Premium to draft better contracts faster.